Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Niranjanon Feb 09, 2021 5:08pm
223 Views
Post# 32518985

RE:Rob Fia has to wake up and give us a news

RE:Rob Fia has to wake up and give us a news

I don't think there can be short cuts in Scientific Processes and I don't think THRM will take a chance to rush things and make a big mistake in approval process. They may be carefully taking all the scenarios to avoid whatever that can go wrong. And delivering the highest value to the shareholders. Just imaging if they rush and not get the approval from authorities. Share price will be back to $0.02 - $0.03. (correct me if I am wrong) a very small mistake is more than enough for the share price to go back to pre-covid levels. 

Again this is 100% my view and I do restpect all other views. I am not a basher or a pamper but I have invested a "Small amount of Hard Earned Money" (not borrowed), So when there is no NR I too get panic as a average human being.

<< Previous
Bullboard Posts
Next >>